US Patent Issued to NANJING HANWEI PUBLIC HEALTH TECHNOLOGY on Nov. 18 for "Prediction system for identifying key heterogeneous molecules driving tumor metastasis" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,475,972, issued on Nov. 18, was assigned to NANJING HANWEI PUBLIC HEALTH TECHNOLOGY Co. LTD. (Nanjing, China).

"Prediction system for identifying key heterogeneous molecules driving tumor metastasis" was invented by Jianwei Zhou (Nanjing, China), Jiahua Cui (Nanjing, China), Chuanjun Shu (Nanjing, China), Junjie Chen (Nanjing, China) and Aiping Li (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A prediction system for identifying key heterogeneous molecules that drive tumor metastasis including an input module, an analysis module, and an output module. The input module is configured to input a first quantitative analysis result of protein...